• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Longboard Pharmaceuticals Inc.

    11/8/24 5:15:02 PM ET
    $LBPH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $LBPH alert in real time by email
    SC 13G/A 1 lbph_13ga.htm
       
       
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC  20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No. 4)   *


    Longboard Pharmaceuticals, Inc.
    (Name of Issuer)
     
    Voting Common Stock, par value $0.0001 per share
    (Title of Class of Securities)
     
    54300N103
    (Cusip Number)
     
    September 30, 2024
    (Date of Event which Requires Filing of this Statement)
     
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐
    Rule 13d-1(b)
    ☒
    Rule 13d-1(c)
    ☐
    Rule 13d-1(d)

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).








    (Continued on following pages)
    Page 1 of 36 Pages
    Exhibit Index Found on Page 35


    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Zone II Healthcare Holdings, LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    116,501 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    116,501 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    116,501 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.3% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    OO

    1 Includes 116,501 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 1,642,999 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 2 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon Capital Partners, L.P.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    California
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    493,656
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    493,656
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    493,656
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    1.4%
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    PN



    Page 3 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon Capital Institutional Partners, L.P.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    California
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    503,394
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    503,394
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    503,394
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    1.5%
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    PN



    Page 4 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon Capital Institutional Partners II, L.P.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    California
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    159,618
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    159,618
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    159,618
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.5%
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    PN



    Page 5 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon Capital Institutional Partners III, L.P.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    72,164
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    72,164
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    72,164
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.2%
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    PN



    Page 6 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Four Crossings Institutional Partners V, L.P.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    102,840
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    102,840
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    102,840
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.3%
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    PN



    Page 7 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon Capital Offshore Investors II, L.P.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Cayman Islands
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    889,195
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    889,195
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    889,195
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    2.6%
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    PN



    Page 8 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon Capital F5 Master I, L.P.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Cayman Islands
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    245,513
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    245,513
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    245,513
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.7%
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    PN



    Page 9 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon Capital (AM) Investors, L.P.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    56,094
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    56,094
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    56,094
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.2%
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    PN



    Page 10 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon Healthcare Partners Master, L.P.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Cayman Islands
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    817,088 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    817,088 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    817,088 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    2.4% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    PN

    1 Includes 188,705 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 2,661,295 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 11 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon Capital Management, L.L.C.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    116,501 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    116,501 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    116,501 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.3% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    OO

    1 Includes 116,501 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 1,642,999 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 12 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon Partners, L.L.C.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,094,049
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,094,049
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,094,049
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.0%
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    OO

    1 Includes 188,705 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 2,661,295 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 13 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon Institutional (GP) V, L.L.C.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    102,840
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    102,840
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    102,840
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.3%
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    OO



    Page 14 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon F5 (GP), L.L.C.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    245,513
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    245,513
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    245,513
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    0.7%
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    OO



    Page 15 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Farallon Healthcare Partners (GP), L.L.C.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    817,088 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    817,088 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    817,088 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    2.4% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    OO

    1 Includes 188,705 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 2,661,295 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 16 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Joshua J. Dapice
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 17 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Philip D. Dreyfuss
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
      3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 18 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Hannah E. Dunn
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
      3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 19 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Richard B. Fried
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 20 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Varun N. Gehani
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 21 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Nicolas Giauque
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    France
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 22 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    David T. Kim
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 23 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Michael G. Linn
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).



    Page 24 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Rajiv A. Patel
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).



    Page 25 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Thomas G. Roberts, Jr.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 26 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Edric C. Saito
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 27 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    William Seybold
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 28 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Daniel S. Short
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 29 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Andrew J. M. Spokes
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United Kingdom
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 30 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    John R. Warren
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99%  1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 31 of 36 Pages

    13G
    CUSIP No. 54300N103
     

    1
    NAMES OF REPORTING PERSONS
     
    Mark C. Wehrly
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)            
                                                                                                                                                          (a) [     ]
                                                                                                                                                          (b) [ X ]**
    ** The reporting persons making this filing hold an aggregate of 3,150,857 Shares (as defined in Item 2), and hold Non-Voting Shares (as defined in the Preliminary Note) convertible into up to an aggregate of 4,609,500 Shares.  Due to exercise limitations applicable to the Non-Voting Shares, as of the date of this filing the reporting persons have the right to convert Non-Voting Shares into up to an aggregate of 305,206 Shares.  Accordingly, as of the date of this filing the aggregate Shares and Non-Voting Shares held by the reporting persons represent beneficial ownership of 9.99% of the class of Shares.  The reporting person on this cover page, however, is a beneficial owner only of the securities reported by it on this cover page.
     
    3
    SEC USE ONLY
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
    5
    SOLE VOTING POWER
     
    -0-
    6
    SHARED VOTING POWER
     
    3,456,063 1
    7
    SOLE DISPOSITIVE POWER
     
    -0-
    8
    SHARED DISPOSITIVE POWER
     
    3,456,063 1
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    3,456,063 1
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
    CERTAIN SHARES (See Instructions)                         
                                                                                                                                                                [     ]
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    9.99% 1
    12
    TYPE OF REPORTING PERSON (See Instructions)
     
    IN

    1 Includes 305,206 Shares into which Non-Voting Shares are convertible within 60 days hereof.  Excludes 4,304,294 Shares into which Non-Voting Shares are not convertible within 60 days hereof due to the Beneficial Ownership Limitation (as defined in the Preliminary Note).


    Page 32 of 36 Pages


    This Amendment No. 4 to Schedule 13G amends and restates in its entirety the Schedule 13G initially filed on March 25, 2021 (together with all prior and current amendments thereto, this “Schedule 13G”).

    Preliminary Note:

    As of the date hereof, ZIIHH LLC and the Farallon Funds hold an aggregate of 3,150,857 Shares and 4,609,500 non-voting shares (the “Non-Voting Shares”), each of which is convertible, pursuant to the terms thereof, into one Share.

    The terms of the Non-Voting Shares provide that Non-Voting Shares may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 9.99% of the Shares then issued and outstanding (the “Beneficial Ownership Limitation”).  As of the date hereof, the Beneficial Ownership Limitation permits ZIIHH LLC and the Farallon Funds to convert Non-Voting Shares into an aggregate of not more than 305,206 Shares.  In providing the beneficial ownership information set forth herein, the Reporting Persons have assumed that the aggregate remaining 4,304,294 Non-Voting Shares held by ZIIHH LLC and the Farallon Funds are not exercisable due to the Beneficial Ownership Limitation.

    Capitalized terms used in this Preliminary Note without definitions have the meanings ascribed to them below.

    Item 1. Issuer

    (a) Name of Issuer:

    Longboard Pharmaceuticals, Inc. (the “Company”)

    (b) Address of Issuer’s Principal Executive Offices:

    4275 Executive Square, Suite 950
    La Jolla, CA 92037

    Item 2. Identity and Background

    Title of Class of Securities and CUSIP Number (Items 2(d) and (e))

    This statement relates to shares of voting common stock, par value $0.0001 per share (the “Shares”), of the Company.  The CUSIP number of the Shares is 54300N103.

    Name of Persons Filing, Address of Principal Business Office and Citizenship (Items 2(a), (b) and (c))

    This statement is filed by the entities and persons listed below, all of whom together are referred to herein as the “Reporting Persons”.

    ZIIHH LLC

    (i)
    Zone II Healthcare Holdings, LLC, a Delaware limited liability company (“ZIIHH LLC”), with respect to the Shares it has the right to acquire upon the conversion of Non-Voting Shares.

    The Farallon Funds

    (ii)
    Farallon Capital Partners, L.P., a California limited partnership (“FCP”), with respect to the Shares held by it;

    (iii)
    Farallon Capital Institutional Partners, L.P., a California limited partnership (“FCIP”), with respect to the Shares held by it;

    (iv)
    Farallon Capital Institutional Partners II, L.P., a California limited partnership (“FCIP II”), with respect to the Shares held by it;

    (v)
    Farallon Capital Institutional Partners III, L.P., a Delaware limited partnership (“FCIP III”), with respect to the Shares held by it;

    (vi)
    Four Crossings Institutional Partners V, L.P., a Delaware limited partnership (“FCIP V”), with respect to the Shares held by it;

    (vii)
    Farallon Capital Offshore Investors II, L.P., a Cayman Islands exempted limited partnership (“FCOI II”), with respect to the Shares held by it;

    (viii)
    Farallon Capital F5 Master I, L.P., a Cayman Islands exempted limited partnership (“F5MI”), with respect to the Shares held by it;

    (ix)
    Farallon Capital (AM) Investors, L.P., a Delaware limited partnership (“FCAMI”), with respect to the Shares held by it; and

    (x)
    Farallon Healthcare Partners Master, L.P., a Cayman Islands exempted limited partnership (“FHPM”), with respect to the Shares held by it and the Shares it has the right to acquire upon the conversion of Non-Voting Shares.

    FCP, FCIP, FCIP II, FCIP III, FCIP V, FCOI II, F5MI, FCAMI and FHPM are together referred to herein as the “Farallon Funds.”

    The Management Company

    (xi)
    Farallon Capital Management, L.L.C., a Delaware limited liability company (the “Management Company”), which is the manager of ZIIHH LLC, with respect to the Shares ZIIHH LLC has the right to acquire upon the conversion of Non-Voting Shares.

    The Farallon General Partner

    (xii)
    Farallon Partners, L.L.C., a Delaware limited liability company (the “Farallon General Partner”), which is the general partner of each of FCP, FCIP, FCIP II, FCIP III, FCOI II and FCAMI and the sole member of each of the FCIP V General Partner (as defined below) and the FHPM General Partner (as defined below), with respect to the Shares held by each of the Farallon Funds other than F5MI and the Shares FHPM has the right to acquire upon the conversion of Non-Voting Shares.

    The FCIP V General Partner

    (xiii)
    Farallon Institutional (GP) V, L.L.C., a Delaware limited liability company (the “FCIP V General Partner”), which is the general partner of FCIP V, with respect to the Shares held by FCIP V.

    The F5MI General Partner

    (xiv)
    Farallon F5 (GP), L.L.C., a Delaware limited liability company (the “F5MI General Partner”), which is the general partner of F5MI, with respect to the Shares held by F5MI.

    The FHPM General Partner

    (xv)
    Farallon Healthcare Partners (GP), L.L.C., a Delaware limited liability company (the “FHPM General Partner”), which is the general partner of FHPM, with respect to the Shares held by FHPM and the Shares FHPM has the right to acquire upon the conversion of Non-Voting Shares.

    The Farallon Individual Reporting Persons

    (xvi)
    The following persons, each of whom is a managing member or senior managing member, as the case may be, of the Management Company and the Farallon General Partner, and a manager or senior manager, as the case may be, of the FCIP V General Partner, the F5MI General Partner and the FHPM General Partner, with respect to the Shares held by the Farallon Funds and the Shares ZIIHH LLC and FHPM have the right to acquire upon the conversion of Non-Voting Shares:  Joshua J. Dapice (“Dapice”); Philip D. Dreyfuss (“Dreyfuss”); Hannah E. Dunn (“Dunn”); Richard B. Fried (“Fried”); Varun N. Gehani (“Gehani”); Nicolas Giauque (“Giauque”); David T. Kim (“Kim”); Michael G. Linn (“Linn”); Rajiv A. Patel (“Patel”); Thomas G. Roberts, Jr. (“Roberts”); Edric C. Saito (“Saito”); William Seybold (“Seybold”); Daniel S. Short (“Short”); Andrew J. M. Spokes (“Spokes”); John R. Warren (“Warren”); and Mark C. Wehrly (“Wehrly”).

    Dapice, Dreyfuss, Dunn, Fried, Gehani, Giauque, Kim, Linn, Patel, Roberts, Saito, Seybold, Short, Spokes, Warren and Wehrly are together referred to herein as the “Farallon Individual Reporting Persons.”

    The citizenship of each of ZIIHH LLC, the Farallon Funds, the Management Company, the Farallon General Partner, the FCIP V General Partner, the F5MI General Partner and the FHPM General Partner is set forth above. Each of the Farallon Individual Reporting Persons, other than Giauque and Spokes, is a citizen of the United States.  Giauque is a citizen of France.  Spokes is a citizen of the United Kingdom.  The address of the principal business office of each of the Reporting Persons is c/o Farallon Capital Management, L.L.C., One Maritime Plaza, Suite 2100, San Francisco, California 94111.

    Item 3.
    If This Statement Is Filed Pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c),         Check Whether the Person Filing Is an Entity Specified in (a) - (k):

    Not applicable.

    Item 4. Ownership

    The information required by Items 4(a) – (c) and set forth in Rows 5 through 11 of the cover page for each Reporting Person is incorporated herein by reference for each such Reporting Person.

    The Non-Voting Shares reported hereby for ZIIHH LLC are held directly by ZIIHH LLC. The Shares and Non-Voting Shares reported hereby for the respective Farallon Funds are held directly by the respective Farallon Funds.  The Management Company, as the manager of ZIIHH LLC, may be deemed to be a beneficial owner of such Non-Voting Shares held by ZIIHH LLC.  The Farallon General Partner, as the general partner of each of FCP, FCIP, FCIP II, FCIP III, FCOI II and FCAMI, and as the sole member of the FCIP V General Partner and the FHPM General Partner, may be deemed to be a beneficial owner of such Shares and Non-Voting Shares held by the Farallon Funds other than F5MI.  The FCIP V General Partner, as the general partner of FCIP V, may be deemed to be a beneficial owner of such Shares held by FCIP V. The F5MI General Partner, as the general partner of F5MI, may be deemed to be a beneficial owner of such Shares held by F5MI.  The FHPM General Partner, as the general partner of FHPM, may be deemed to be a beneficial owner of all such Shares and Non-Voting Shares held by FHPM.  Each of the Farallon Individual Reporting Persons, as a managing member or senior managing member, as the case may be, of the Management Company and the Farallon General Partner, and as a manager or senior manager, as the case may be, of the FCIP V General Partner, the F5MI General Partner and the FHPM General Partner, in each case with the power to exercise investment discretion, may be deemed to be a beneficial owner of such Shares and Non-Voting Shares held by ZIIHH LLC and the Farallon Funds.  Each of the Management Company, the Farallon General Partner, the FCIP V General Partner, the F5MI General Partner, the FHPM General Partner and the Farallon Individual Reporting Persons hereby disclaims any beneficial ownership of any such Shares and Non-Voting Shares.

    Item 5. Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof each of the Reporting Persons has ceased to be a beneficial owner of more than five percent of the class of securities, check the following:

    Item 6. Ownership of More than Five Percent on Behalf of Another Person

    Not applicable.

    Item 7.
    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

     Not applicable.

    Item 8.
    Identification and Classification of Members of the Group

    The Reporting Persons are filing this Schedule 13G pursuant to Section 240.13d-1(c).  Consistent with Item 2 of the cover page for each Reporting Person above, the Reporting Persons neither disclaim nor affirm the existence of a group among them.

    Item 9. Notice of Dissolution of Group

    Not applicable.

    Item 10. Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.


    Page 33 of 36 Pages

    SIGNATURES

    After reasonable inquiry and to the best of our knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.
    Dated:  November 8, 2024

     
    /s/ Hannah E. Dunn
     
    FARALLON CAPITAL MANAGEMENT, L.L.C.,
     
    On its own behalf and
     
    As the Manager of
     
    ZONE II HEALTHCARE HOLDINGS, LLC
     
    By Hannah E. Dunn, Managing Member
       
     
    /s/ Hannah E. Dunn
     
    FARALLON PARTNERS, L.L.C.,
     
    On its own behalf and
     
    As the General Partner of
     
    FARALLON CAPITAL PARTNERS, L.P.,
     
    FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.,
     
    FARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.,
     
    FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.,
     
    FARALLON CAPITAL OFFSHORE INVESTORS II, L.P., and
     
    FARALLON CAPITAL (AM) INVESTORS, L.P.
     
    By Hannah E. Dunn, Managing Member
       
     
    /s/ Hannah E. Dunn
     
    FARALLON INSTITUTIONAL (GP) V, L.L.C.,
     
    On its own behalf and
     
    As the General Partner of
     
    FOUR CROSSINGS INSTITUTIONAL PARTNERS V, L.P.
     
    By Hannah E. Dunn, Manager
       
     
    /s/ Hannah E. Dunn
     
    FARALLON F5 (GP), L.L.C.,
     
    On its own behalf and
     
    As the General Partner of
     
    FARALLON CAPITAL F5 MASTER I, L.P.
     
    By Hannah E. Dunn, Manager
       
     
    /s/ Hannah E. Dunn
     
    FARALLON HEALTHCARE PARTNERS (GP), L.L.C.
     
    On its own behalf and
     
    As the General Partner of
     
    FARALLON HEALTHCARE PARTNERS MASTER, L.P.
     
    By Hannah E. Dunn, Manager
       
     
    /s/ Hannah E. Dunn
     
    Hannah E. Dunn, individually and as attorney-in-fact for each of Joshua J. Dapice, Philip D. Dreyfuss, Richard B. Fried, Varun N. Gehani, Nicolas Giauque, David T. Kim, Michael G. Linn, Rajiv A. Patel, Thomas G. Roberts, Jr., Edric C. Saito, William Seybold, Daniel S. Short, Andrew J. M. Spokes, John R. Warren and Mark C. Wehrly

    The Powers of Attorney executed by each of Dapice, Dreyfuss, Fried, Gehani, Giauque, Kim, Linn, Patel, Roberts, Saito, Seybold, Short, Spokes, Warren and Wehrly authorizing Dunn to sign and file this Schedule 13G on his behalf, which were filed as exhibits to the Schedule 13G filed with the Securities and Exchange Commission on January 31, 2023 by such Reporting Persons with respect to the Class A Ordinary Shares of ARYA Sciences Acquisition Corp IV, are hereby incorporated by reference.


    Page 34 of 36 Pages


    EXHIBIT INDEX


    EXHIBIT 1
    Joint Acquisition Statement Pursuant to Section 240.13d-1(k)
     


    Page 35 of 36 Pages

    EXHIBIT 1
    to
    SCHEDULE 13G

    JOINT ACQUISITION STATEMENT
    PURSUANT TO SECTION 240.13d-1(k)

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements.  The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him, her or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate.

    Dated:  November 8, 2024

     
    /s/ Hannah E. Dunn
     
    FARALLON CAPITAL MANAGEMENT, L.L.C.,
     
    On its own behalf and
     
    As the Manager of
     
    ZONE II HEALTHCARE HOLDINGS, LLC
     
    By Hannah E. Dunn, Managing Member
       
     
    /s/ Hannah E. Dunn
     
    FARALLON PARTNERS, L.L.C.,
     
    On its own behalf and
     
    As the General Partner of
     
    FARALLON CAPITAL PARTNERS, L.P.,
     
    FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.,
     
    FARALLON CAPITAL INSTITUTIONAL PARTNERS II, L.P.,
     
    FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.,
     
    FARALLON CAPITAL OFFSHORE INVESTORS II, L.P., and
     
    FARALLON CAPITAL (AM) INVESTORS, L.P.
     
    By Hannah E. Dunn, Managing Member
       
     
    /s/ Hannah E. Dunn
     
    FARALLON INSTITUTIONAL (GP) V, L.L.C.,
     
    On its own behalf and
     
    As the General Partner of
     
    FOUR CROSSINGS INSTITUTIONAL PARTNERS V, L.P.
     
    By Hannah E. Dunn, Manager
       
     
    /s/ Hannah E. Dunn
     
    FARALLON F5 (GP), L.L.C.,
     
    On its own behalf and
     
    As the General Partner of
     
    FARALLON CAPITAL F5 MASTER I, L.P.
     
    By Hannah E. Dunn, Manager
       
     
    /s/ Hannah E. Dunn
     
    FARALLON HEALTHCARE PARTNERS (GP), L.L.C.
     
    On its own behalf and
     
    As the General Partner of
     
    FARALLON HEALTHCARE PARTNERS MASTER, L.P.
     
    By Hannah E. Dunn, Manager
       
     
    /s/ Hannah E. Dunn
     
    Hannah E. Dunn, individually and as attorney-in-fact for each of Joshua J. Dapice, Philip D. Dreyfuss, Richard B. Fried, Varun N. Gehani, Nicolas Giauque, David T. Kim, Michael G. Linn, Rajiv A. Patel, Thomas G. Roberts, Jr., Edric C. Saito, William Seybold, Daniel S. Short, Andrew J. M. Spokes, John R. Warren and Mark C. Wehrly



    Page 36 of 36 Pages
    Get the next $LBPH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $LBPH

    DatePrice TargetRatingAnalyst
    9/10/2024$60.00Buy
    Truist
    7/1/2024$60.00 → $90.00Overweight
    Cantor Fitzgerald
    5/1/2024$36.00Outperform
    Robert W. Baird
    2/16/2024$40.00Buy
    Citigroup
    10/24/2023$16.00 → $35.00Overweight
    Cantor Fitzgerald
    4/27/2023$13.00Buy
    B. Riley Securities
    2/14/2022$14.00Outperform
    Wedbush
    More analyst ratings

    $LBPH
    Financials

    Live finance-specific insights

    See more
    • Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline

      The proposed acquisition represents a significant step forward in Lundbeck's Focused Innovator strategy, adding a highly innovative and complementary product in late-stage development for Developmental and Epileptic Encephalopathies (DEEs) - an area of high unmet medical need The acquisition will enhance and complement Lundbeck's capabilities and presence within neuro-rare conditions The lead asset, bexicaserin, holds blockbuster potential and is in development for the treatment of DEEs in a program enrolling patients diagnosed with Dravet syndrome, Lennox-Gastaut syndrome, and other DEE syndromes Bexicaserin has shown encouraging anti-seizure effects to date in preclinical and clini

      10/14/24 6:30:00 AM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Longboard Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

      Bexicaserin (LP352) received Breakthrough Therapy designation (BTD) for the treatment of seizures associated with Developmental and Epileptic Encephalopathies (DEEs) for patients two years of age or older Bexicaserin demonstrated a sustained, durable response in seizure reduction and a favorable safety and tolerability profile across a broad range of DEEs in an interim analysis of the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Completed End of Phase 2 Meeting to discuss Longboard's global Phase 3 program for bexicaserin, which is on track to initiate in H2 2024 Longboard plans to host an Investor & Analyst Event on September 16 to highlight details of the global P

      8/1/24 4:01:00 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Longboard Pharmaceuticals to Report Second Quarter 2024 Financial Results and Host Corporate Update Call on August 1

      Conference call to discuss corporate updates, including Phase 1 single ascending dose (SAD) topline data for LP659 in healthy volunteers Conference call and webcast to be held August 1 at 4:30pm ET (1:30pm PT) Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it plans to release second quarter 2024 financial results and provide a corporate update, including topline Phase 1 SAD data for LP659, its centrally acting, highly selective sphingosine-1-phosphate (S1P) receptor modulator, on August 1, 2024. The Company will host a conference call and we

      7/29/24 9:15:00 AM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $LBPH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CMO Kaye Randall bought $2,482 worth of shares (100 units at $24.82), sold $580,891 worth of shares (16,767 units at $34.64) and exercised 16,667 shares at a strike of $4.35 (SEC Form 4)

      4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)

      8/13/24 6:01:53 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $LBPH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Sensorion Strengthens Leadership Team with Appointment of Amit Munshi as Chairman of the Board and Independent Director

      Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced the appointment of Amit Munshi, as Sensorion's independent director and Chairman of the Board, effective April 1, 2025. Mr. Munshi succeeds Mr. John Furey who stepped down as an Independent Board Member. Mr. Munshi is then appointed Chairman of the Board, replacing Khalil Barrage who served as the Company's interim Chairman since March 31, 2023. Mr. Barrage will continue to serve as a director on Sensorion's Board. This appointment by the Board of directors is performed b

      4/2/25 1:30:00 AM ET
      $LBPH
      $ARNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)

      DEEp OCEAN is the first pivotal clinical trial designed to study DEEs broadly Initial sites activated with additional sites expected to be activated in the coming weeks Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it has initiated its global Phase 3 DEEp OCEAN Study evaluating its investigational drug bexicaserin for the treatment of seizures associated with Developmental and Epileptic Encephalopathies (DEEs) in participants two years of age and older. "The initiation of our second global Phase 3 clinical trial, DEEp OCEAN in DEEs, is a

      11/12/24 8:30:00 AM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

      Positive opinion of Paediatric Investigation Plan for bexicaserin issued by European Medicines Agency (EMA) Paediatric Committee (PDCO) for children down to the age of 2 years Recently initiated Phase 3 global clinical trial (the DEEp SEA Study) to evaluate bexicaserin in Dravet syndrome for participants ages 2-65 years Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported third quarter 2024 financial results. RECENT UPDATES: In October, announced an agreement for H. Lundbeck A/S (Lundbeck) to acquire Longboard in a stra

      11/7/24 4:01:00 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $LBPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Lynch Casey

      4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)

      12/2/24 7:29:28 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Le Goff Corinne

      4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)

      12/2/24 7:27:57 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 4 filed by Director Sekhri Paul J

      4 - Longboard Pharmaceuticals, Inc. (0001832168) (Issuer)

      12/2/24 7:26:22 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $LBPH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Truist initiated coverage on Longboard Pharmaceuticals with a new price target

      Truist initiated coverage of Longboard Pharmaceuticals with a rating of Buy and set a new price target of $60.00

      9/10/24 7:53:02 AM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Cantor Fitzgerald reiterated coverage on Longboard Pharmaceuticals with a new price target

      Cantor Fitzgerald reiterated coverage of Longboard Pharmaceuticals with a rating of Overweight and set a new price target of $90.00 from $60.00 previously

      7/1/24 12:54:07 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Robert W. Baird initiated coverage on Longboard Pharmaceuticals with a new price target

      Robert W. Baird initiated coverage of Longboard Pharmaceuticals with a rating of Outperform and set a new price target of $36.00

      5/1/24 6:27:25 AM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $LBPH
    SEC Filings

    See more
    • SEC Form 15-12G filed by Longboard Pharmaceuticals Inc.

      15-12G - Longboard Pharmaceuticals, Inc. (0001832168) (Filer)

      12/12/24 8:10:02 AM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form POSASR filed by Longboard Pharmaceuticals Inc.

      POSASR - Longboard Pharmaceuticals, Inc. (0001832168) (Filer)

      12/10/24 3:53:35 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form RW WD filed by Longboard Pharmaceuticals Inc.

      RW WD - Longboard Pharmaceuticals, Inc. (0001832168) (Filer)

      12/10/24 3:40:14 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $LBPH
    Leadership Updates

    Live Leadership Updates

    See more
    • Sensorion Strengthens Leadership Team with Appointment of Amit Munshi as Chairman of the Board and Independent Director

      Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced the appointment of Amit Munshi, as Sensorion's independent director and Chairman of the Board, effective April 1, 2025. Mr. Munshi succeeds Mr. John Furey who stepped down as an Independent Board Member. Mr. Munshi is then appointed Chairman of the Board, replacing Khalil Barrage who served as the Company's interim Chairman since March 31, 2023. Mr. Barrage will continue to serve as a director on Sensorion's Board. This appointment by the Board of directors is performed b

      4/2/25 1:30:00 AM ET
      $LBPH
      $ARNA
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Longboard Pharmaceuticals Announces the Appointment of Highly Accomplished Healthcare Executive Randall Kaye, M.D., as Chief Medical Officer

      SAN DIEGO, March 21, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced the appointment of Dr. Randall Kaye as Chief Medical Officer (CMO). Dr. Philip Perera, who has led the clinical development and medical affairs activities since the launch of Longboard, has retired as CMO while remaining with Longboard in an advisory role. "On behalf of the board, shareholders, and our employees, I want to thank Phil for his tremendous contributions," said Kevin R. Lind, Longboard's President and Chief Executive Officer. "His outstanding leade

      3/21/22 4:01:00 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results

      Initiated the Phase 1b/2a PACIFIC Study, evaluating LP352 in participants with developmental and epileptic encephalopathies (DEEs)LP352 demonstrated statistically significant reduction of epileptiform event frequency and duration in the scn1lab zebrafish model of Dravet syndromeLP659 IND submission remains on track for second half of 2022Cash position expected to support operations into 2024 based on current business plan SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) --  Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported financ

      3/3/22 4:05:00 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $LBPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Longboard Pharmaceuticals Inc.

      SC 13G/A - Longboard Pharmaceuticals, Inc. (0001832168) (Subject)

      11/14/24 3:10:34 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Longboard Pharmaceuticals Inc.

      SC 13G/A - Longboard Pharmaceuticals, Inc. (0001832168) (Subject)

      11/14/24 1:22:40 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Longboard Pharmaceuticals Inc.

      SC 13G/A - Longboard Pharmaceuticals, Inc. (0001832168) (Subject)

      11/12/24 3:59:14 PM ET
      $LBPH
      Biotechnology: Pharmaceutical Preparations
      Health Care